Advances in the medical management of benign prostatic hyperplasia

Jewett, Michael A. S.; Klotz, Laurence H.
June 2007
CMAJ: Canadian Medical Association Journal;6/19/2007, Vol. 176 Issue 13, p1850
Academic Journal
The article discusses the advancement in the medical management of benign prostatic hyperplasia (BPH) in men. The results from the Medical Therapy of Prostatic Symptoms found that the use of doxazosin in combination with finasteride slowed down the clinical progression of BPH, particularly in high-risks group. In addition, the Prostate Cancer Prevention Trial showed that the finasteride therapy improved the urinary infections of patients and reduced the risk of prostate cancer.


Related Articles

  • PAE Safe, Effective for BPH.  // Renal & Urology News;Dec2013, Vol. 12 Issue 12, p22 

    The article reports on an early clinical trial conducted by Sandeep Bagla and colleagues which reveals that prostatic artery embolization (PAE) is a safe and effective treatment for benign prostatic hyperplasia (BPH).

  • Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction. Abolyosr, Ahmed; ElSagheer, Gamal A.; Abdel-Kader, Mohammad S.; Hassan, Ahmed M.; Abou-Zeid, Abdel-Monem M. // Urology Annals;Oct2013, Vol. 5 Issue 4, p237 

    Purpose: To verify the association between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) and evaluate the influence of sildenafil and doxazosin either as single agents or combined on both symptoms. Material and Methods: A prospective randomized study including 150 patients...

  • FINASTERIDE FOR BPH. Johnson, Kenneth H.; Casey, Cynthia M. // Journal of Family Practice;Jun1998, Vol. 46 Issue 6, p455 

    The article reviews the study "The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men With Benign Prostatic Hyperplasia," by J. D. McConnell, R. Bruskewitz, P. Walsh et al, which appeared in a 1998 issue of the "New England Journal of...

  • Independent Nurse: Clinical Focus - Benign prostatic hyperplasia. Rees, Rowland // GP: General Practitioner;11/27/2009, p21 

    The article presents information related to Benign Prostatic Hyperplasia (BPH), which occurs due to an increase in epithelial and stromal cells in the peri-urethral area of the prostate. It has been stated that BPH could be detected by performing urinalysis. It has also been reported that...

  • Drugs that work for enlarged prostate. Napoli, Maryann // Center for Medical Consumers;Oct2010, p1 

    The article discusses a new Cochrane review of clinical trials for drugs for enlarged prostate or benign prostatic hyperplasia (BPH). The review of 23 randomized clinical trials found that finasteride, or Proscar, slows the enlargement of the prostate gland. It also found that blood pressure...

  • Risk of BPH complcations drops in largest study of... Bankhead, Charles // Urology Times;Nov97, Vol. 25 Issue 11, p3 

    Discusses the effectivity of finasteride in treating benign prostatic hyperplasia. Condition of the patient used in the study; Percentage of prostate volume decreased with finasteride; Difference between finasteride and placebo; Condition of patient with a better finasteride therapy effect.

  • The PVP procedure for BPH: Long-term Outcomes. Te, Alexis E. // Urology Times;Jan2007, Vol. 35 Issue 1, p14 

    The article evaluates the data surrounding the long-term durability and the state of photoselective laser vaporization of the prostate (PVP) for treating benign prostatic hyperplasia. Previous studies found that PVP did not have adverse events such as postoperative urinary retention, infection,...

  • Diagnosis and Management of Benign Prostatic Hyperplasia. Edwards, Jonathan L. // American Family Physician;5/15/2008, Vol. 77 Issue 10, p1403 

    Benign prostatic hyperplasia is a common condition affecting older men. Typical presenting symptoms include urinary hesitancy, weak stream, nocturia, incontinence, and recurrent urinary tract infections. Acute urinary retention, which requires urgent bladder catheterization, is relatively...

  • How do I treat and follow my TUNA patients. Barmoshe, Sas; Zlotta, Alexandre R. // World Journal of Urology;Aug2006, Vol. 24 Issue 4, p397 

    Transurethral needle ablation (TUNA) of the prostate is an alternative treatment for benign prostatic hyperplasia (BPH) generating temperatures around 100°C leading to necrotic lesions inside the prostate. TUNA is a minimally invasive, low morbidity associated, approach that uses...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics